FdaApplication

ANDA 218502

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2025-06-26

Products (1)

ProductActive ingredientStrengthDosage form
RIVAROXABANRIVAROXABAN1MG/MLFOR SUSPENSION;ORAL

1 product